Autolus Therapeutics's total assets for Q3 2025 were $661.95M, a decrease of -8.19% from the previous quarter. AUTL total liabilities were $396.50M for the fiscal quarter, a 5.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.